Zobrazeno 1 - 10
of 76
pro vyhledávání: '"R Andrew McIvor"'
Publikováno v:
Canadian Respiratory Journal, Vol 18, Iss 6, Pp 327-332 (2011)
BACKGROUND: Chronic obstructive pulmonary disease (COPD) and asthma are common; however, mortality rates among individuals with these diseases are not well studied in North America.
Externí odkaz:
https://doaj.org/article/a032737dfd3643c98ab7207cab6852ed
Autor:
Louis-Philippe Boulet, J Mark FitzGerald, R Andrew McIvor, Sabrina Zimmerman, Kenneth R Chapman
Publikováno v:
Canadian Respiratory Journal, Vol 15, Iss 5, Pp 275-279 (2008)
BACKGROUND: In patients with asthma, smoking has been associated with accelerated decline in pulmonary function, poor disease control and reduced responsiveness to corticosteroids.
Externí odkaz:
https://doaj.org/article/bd072e6c26c944b69ca7dd41ad61e3fc
Autor:
J Mark FitzGerald, Louis-Philippe Boulet, R Andrew McIvor, Sabrina Zimmerman, Kenneth R Chapman
Publikováno v:
Canadian Respiratory Journal, Vol 13, Iss 5, Pp 253-259 (2006)
BACKGROUND: Two Canadian studies showed that 55% of patients with asthma had daily symptoms (in 1996) and that 57% of patients suffered from poorly controlled asthma (in 1999).
Externí odkaz:
https://doaj.org/article/8d881d47d0304b16b6b9deaa67133f5e
Publikováno v:
Canadian Journal of Infectious Diseases, Vol 14, Iss 5, Pp 254-259 (2003)
OBJECTIVE: To compare the mean time to next exacerbation in patients with acute exacerbations of chronic obstructive pulmonary disease (COPD) before and after the implementation of standing orders.
Externí odkaz:
https://doaj.org/article/d811df61f6b9423f9d47768784d3aa5e
Autor:
R Andrew McIvor, Donald P Tashkin
Publikováno v:
Canadian Respiratory Journal, Vol 8, Iss 3, Pp 153-158 (2001)
Chronic obstructive pulmonary disease (COPD) is associated with significant morbidity and mortality. It is the fourth leading cause of death in the United States, and its impact on quality of life can be severe. The debate on spirometry as a screenin
Externí odkaz:
https://doaj.org/article/ebca201099e24e7d8bcb3afe0648bf46
Autor:
Paul K Keith, Caroline Koch, Michel Djandji, Jacques Bouchard, Eliofotisti Psaradellis, John S Sampalis, R Robert Schellenberg, R Andrew McIvor
Publikováno v:
Canadian Respiratory Journal, Vol 16, Iss Suppl A, Pp 17A-24A (2009)
OBJECTIVE: To evaluate the effectiveness of montelukast as add-on therapy for patients diagnosed with asthma and concurrent allergic rhinitis who remain uncontrolled while receiving inhaled corticosteroid (ICS) monotherapy or ICS/long-acting beta-2-a
Externí odkaz:
https://doaj.org/article/6699ebd613144a8298d9bd905de8d821
Montelukast as Add-On Therapy to Inhaled Corticosteroids in the Management of Asthma (The SAS Trial)
Autor:
J Mark FitzGerald, Sylvain Foucart, Stephen Coyle, John Sampalis, Denis Haine, Eliofotisti Psaradellis, R Andrew McIvor
Publikováno v:
Canadian Respiratory Journal, Vol 16, Iss Suppl A, Pp 5A-10A (2009)
AIM: To evaluate the effectiveness of montelukast as add-on therapy for asthmatic patients who remain uncontrolled with low, moderate or high doses of inhaled corticosteroid monotherapy.
Externí odkaz:
https://doaj.org/article/a4336202c9184b97be3288f79c55abf0
Publikováno v:
Canadian Respiratory Journal, Vol 16, Iss Suppl A, Pp 11A-16A (2009)
OBJECTIVE: To evaluate the effectiveness of montelukast as monotherapy for patients with mild asthma who remain uncontrolled or unsatisfied while on inhaled corticosteroid (ICS) monotherapy.
Externí odkaz:
https://doaj.org/article/c1d4bea56a314be4a785419970cd0b6e
Publikováno v:
Canadian Respiratory Journal, Vol 13, Iss Suppl B, Pp 10B-20B (2006)
CONTEXTE : Un nouveau traitement anti-immunoglobuline E (anti-IgE) contre l’asthme, l’omalizumab, a été approuvé au Canada.
Externí odkaz:
https://doaj.org/article/29352d13913e4554a1fb849565874a64
Publikováno v:
Canadian Respiratory Journal, Vol 13, Iss Suppl B, Pp 1B-9B (2006)
BACKGROUND: A novel anti-immunoglobulin E (anti-IgE) therapy for asthma, omalizumab, has been approved for use in Canada.
Externí odkaz:
https://doaj.org/article/de3720d667da4c7095432e571d553d1a